HB Hansa Biopharma AB Stock: price and directors' dealings · Finland · FIN-FSASource id FI:hansa-biopharma-ab ISIN ISIN SE0002148817FI · FIN-FSA Mcap SEK 3.9B 医疗保健 Follow the Hansa Biopharma AB share price and the full management transaction log of the company, a listed equity based in Finland. Shares trade on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Hansa Biopharma AB has recorded 13 reports. Market capitalisation: €3.9bn. The latest transaction was filed on 18 August 2026 (Sale). Among the most active insiders: Michael Bologna. The full history is free.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 August 2026
All Executives13 Thresholds0 Prospectus0 Other0
Declarations 13 total
● Styrelseledamot · Executives · 12 Aug 2026
69,652 shares @ SEK 40.2811 Aktie ISIN ISIN SE0002148817FI:csv-4ba8cb2ae89058777e8e ● Styrelseledamot · Executives · 13 Aug 2026
120,326 shares @ SEK 41.1796 Aktie ISIN ISIN SE0002148817FI:csv-482c3cada3a598ea2014 ● Styrelseledamot · Executives · 14 Aug 2026
83,827 shares @ SEK 39.6935 Aktie ISIN ISIN SE0002148817FI:csv-e5fd20b3bd69698100f4 ● Styrelseledamot · Executives · 29 Jul 2026
23,281 shares @ SEK 37.7036 0.025% mcap 4.9% of flow Aktie ISIN ISIN SE0002148817FI:csv-aa030fb4cac2a5114d03 ● Styrelseledamot · Executives · 27 Jul 2026
271,230 shares @ SEK 37.9322 0.30% mcap 58.0% of flow Aktie ISIN ISIN SE0002148817FI:csv-3907aded8386b461b6ed ● Styrelseledamot · Executives · 28 Jul 2026
172,655 shares @ SEK 38.1294 0.19% mcap 37.1% of flow Aktie ISIN ISIN SE0002148817FI:csv-b913e71014a221ddaf04 ● Annan medlem i bolagets administrations-, lednings- eller kontrollorgan · Executives · 11 Mar 2026
1,688 shares @ €2.7781 0.0002% mcap 100.0% of flow Aktie ISIN ISIN SE0002148817FI:A003W932-1 ● Arbetstagarrepresentant i styrelsen eller arbetstagarsuppleant, Ekonomichef/finanschef/finansdirektör · Executives · 7 Nov 2025
25,000 shares @ €2.8341 0.0025% mcap 100.0% of flow Aktie ISIN ISIN SE0002148817FI:A003T468-1 ● Verkställande direktör (VD) · Executives · 28 Jul 2025
50,000 shares @ €2.4587 0.0043% mcap 7.1% of flow Aktie ISIN ISIN SE0002148817FI:A003R122-1 ● Verkställande direktör (VD) · Executives · 27 Jul 2025
1,652,500 shares @ €0.974 0.056% mcap 92.9% of flow Teckningsoption FI:A003R120-1
● Annan ledande befattningshavare · Executives · 22 Jul 2025
15,050 shares 0
Aktie ISIN ISIN SE0002148817FI:A003R004-1 ● Annan medlem i bolagets administrations-, lednings- eller kontrollorgan · Executives · 22 Jul 2025
8,056 shares @ €2.3631 0.0007% mcap 100.0% of flow Aktie ISIN ISIN SE0002148817FI:A003R005-1 ● Annan medlem i bolagets administrations-, lednings- eller kontrollorgan · Executives · 19 Jan 2021
300 shares @ SEK 185.70 100.0% of flow Aktie ISIN ISIN SE0002148817FI:A001P621-2 关于 Hansa Biopharma AB Hansa Biopharma AB 是一家生物制药公司，致力于为有未满足医疗需求的患者开发治疗方案。该公司在斯德哥尔摩证券交易所上市。